B-220

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameB-220
Drug Alias Name2,3-dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6H-indolo-[2,3-b]quinoxaline9-OH-B-220B-220
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxypharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxypharma Ab
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A